Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy

Effective Control of Polymyalgia Rheumatica With Tocilizumab

(2013) Abdulrahman Al Rashidi et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Tocilizumab for polymyalgia rheumatica: Report of two cases and review of the literature

(2013) Pierluigi Macchioni et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

(2012) Bhaskar Dasgupta et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR)

(2012) Jung Hwa Lee et al.   RHEUMATOLOGY INTERNATIONAL

Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica

(2012) S. Unizony et al.   ARTHRITIS CARE & RESEARCH

The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity

(2011) Marco A Cimmino et al.   BMC MUSCULOSKELETAL DISORDERS

Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica

(2010) K. HAGIHARA et al.   JOURNAL OF RHEUMATOLOGY

Circulating cytokines in active polymyalgia rheumatica

(2009) L Alvarez-Rodriguez et al.   ANNALS OF THE RHEUMATIC DISEASES

BSR and BHPR guidelines for the management of polymyalgia rheumatica

(2009) B. Dasgupta et al.   RHEUMATOLOGY

Performance of the polymyalgia rheumatica activity score for diagnosing disease flares

(2008) Aymeric Binard et al.   ARTHRITIS AND RHEUMATISM

Serum interleukin-6 receptor in polymyalgia rheumatica: A potential marker of relapse/recurrence risk

(2008) Lia Pulsatelli et al.   ARTHRITIS AND RHEUMATISM

Giant cell arteritis and polymyalgia rheumatica: Role of cytokines in the pathogenesis and implications for treatment

(2008) Victor Manuel Martinez-Taboada et al.   CYTOKINE